EUVIMEDEUVIMED entdecken
Crossref

Endocrine Therapy in Low-Grade Serous Ovarian Cancer: From Biological Rationale to Emerging Combination Strategies

Fulvio Borella, Stefano Cosma, Niccolò Gallio, Giorgia Dragone, Stefania Arridu, Giulia Capella, Mathilde Hotot, Eleonora Battista, Paola Cassoni, Isabella Castellano

Oncology Research · 2026 · 1-10

DOI: 10.32604/or.2026.084204 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Fulvio Borella und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Borella, F., Cosma, S., Gallio, N., Dragone, G., Arridu, S., Capella, G., Hotot, M., Battista, E., Cassoni, P., & Castellano, I. (2026). Endocrine Therapy in Low-Grade Serous Ovarian Cancer: From Biological Rationale to Emerging Combination Strategies. Oncology Research, 0(0), 1-10. https://doi.org/10.32604/or.2026.084204

Vancouver

Borella F, Cosma S, Gallio N, Dragone G, Arridu S, Capella G, et al. Endocrine Therapy in Low-Grade Serous Ovarian Cancer: From Biological Rationale to Emerging Combination Strategies. Oncology Research. 2026;0(0):1-10. doi:10.32604/or.2026.084204

BibTeX
@article{Borella2026,
  author = {Borella, Fulvio and Cosma, Stefano and Gallio, Niccolò and Dragone, Giorgia and Arridu, Stefania and Capella, Giulia and Hotot, Mathilde and Battista, Eleonora and Cassoni, Paola and Castellano, Isabella},
  title = {Endocrine Therapy in Low-Grade Serous Ovarian Cancer: From Biological Rationale to Emerging Combination Strategies},
  journal = {Oncology Research},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {1--10},
  doi = {10.32604/or.2026.084204}
}
Kostenlos starten →